Abstract
Background: The aim of this audit is to assess the proportion of patients who underwent sentinel lymph node biopsy after being diagnosed with ductal carcinoma in situ (DCIS). According to the NICE and Surgical guidelines for the management of breast cancer, sentinel lymph node biopsy (SLNB) in patients diagnosed with DCIS should be considered in patients with extensive calcifications, palpable mass or high grade of disease. In addition, SLNB should be performed when mastectomy is the initially planned operation in these patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
